Trials / Completed
CompletedNCT05259293
Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care
Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care: a Retrospective Study in 6 Centers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 243 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax. The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention - retrospective study | This is a retrospective study. No intervention. |
Timeline
- Start date
- 2021-12-09
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-02-28
- Last updated
- 2024-09-19
Locations
6 sites across 3 countries: France, Ireland, United Kingdom
Source: ClinicalTrials.gov record NCT05259293. Inclusion in this directory is not an endorsement.